The search for the genetic contribution to autoimmune thyroid disease: The never ending story?

Briefings in Functional Genomics

Volumn 10, Issue 2, 2011, Pages 77-90

  Simmonds, Matthew J ^a   Gough, Stephen C L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Autoimmune thyroid disease; Candidate gene studies; Cenome wide association screens; Graves'disease; Hashimoto's thyroiditis; Linkage analysis

Indexed keywords

DNA;

ARTICLE; AUTOIMMUNE THYROIDITIS; COPY NUMBER VARIATION; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE IDENTIFICATION; GENE INTERACTION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HERITABILITY; HUMAN; MICROSATELLITE MARKER; PHENOTYPIC VARIATION;

AUTOIMMUNE DISEASES; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHERITANCE PATTERNS; THYROID DISEASES;

EID: 79954461533     PISSN: 20412649     EISSN: None     Source Type: Journal    
DOI: 10.1093/bfgp/elq036     Document Type: Article

References (114)

1. Nakamura Y. DNA variations in human and medical genetics: 25 years of my experience. J Hum Genet 2009;54:1-8.
2. Tomer Y, Barbesino G, Greenberg DA, et al. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 1999;84:4656-64.
3. Tomer Y, Ban Y, Concepcion E, et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003;73:736-47.
4. Imrie H, Vaidya B, Perros P, et al. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J Clin Endocrinol Metab 2001;86:626-30.
5. Vaidya B, Imrie H, Perros P, et al. Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am J Hum Genet 2000;66:1710-4.
6. Taylor JC, Gough SC, Hunt PJ, et al. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab 2006;91:646-53.
7. Simmonds MJ, Gough SCL. Endocrine Autoimmunity. Oxford textbook of Endocrinology and Diabetes. Oxford, UK: Oxford University Press, 2011.
8. Gough SCL, Simmonds MJ. The HLA region and autoimmune disease: Associations and mechanisms of action. Current Genomics 2007;8:453-65.
9. Zeitlin AA, Simmonds MJ, Gough SC. Genetic developments in autoimmune thyroid disease: an evolutionary process. Clin Endocrinol 2008;68:671-82.
10. Sakai K, Shirasawa S, Ishikawa N, et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 2001;10:1379-86.
11. Jin Y, Teng W, Ben S, et al. Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. J Clin Endocrinol Metab 2003;88:1798-1803.
12. Simmonds MJ, Yesmin K, Newby PR, et al. Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease. Thyroid 2010;20:413-7.
13. Song HD, Liang J, Shi JY, et al. Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease. Hum Mol Genet 2009;18:1156-70.
14. Manolio TA, Collins FS. The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med 2009;60:443-56.
15. Almasy L, Blangero J. Human QTL linkage mapping. Genetica 2009;136:333-40.
16. Brand OJ, Gough SC. Genetics of thyroid autoimmunity and the role of the TSHR. Mol Cell Endocrinol 2010;322: 135-43.
17. Brand OJ, Barrett J, Simmonds MJ, et al. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease (GD). Hum Mol Genet 2009; 18:1704-13.
18. Zeitlin AA, Heward JM, Newby PR, et al. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. Genes Immun 2008;9: 358-63.
19. Brand OJ, Lowe CE, Heward JM, et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol 2007;66:508-12.
20. Kochi Y, Yamada R, Suzuki A, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005;37:478-85.
21. Simmonds MJ, Heward JM, Carr-Smith J, et al. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. JClin EndocrinolMetab 2006;91:1056-61.
22. Tomer Y, Davies TF, Greenberg DA. What is the contribution of a Kozak SNP in the CD40 gene to Graves' disease? Clin Endocrinol 2005;62:258.
23. Simmonds MJ, Heward JM, Franklyn JA, et al. The CD40 Kozak SNP: a new susceptibility loci for Graves' disease? Clin Endocrinol 2005;63:232-3.
24. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 1997;278:1580-1.
25. Consortium IH. A haplotype map of the human genome. Nature 2005;437:1299-320.
26. Consortium IH. The International HapMap Project. Nature 2003;426:789-96.
27. Barrett JC, Cardon LR. Evaluating coverage of genomewide association studies. Nat Genet 2006;38:659-62.
28. Pe'er I, de Bakker PI, Maller J, etal. Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet 2006;38:663-67.
29. Pearson TA, Manolio TA. How to interpret a genomewide association study. Jama 2008;299:1335-44.
30. Hunter DJ, Kraft P. Drinking from the fire hose-statistical issues in genomewide association studies. N Engl J Med 2007; 357:436-9.
31. WTCCC, TACS. Association study of 14,500 nsSNPs in four common diseases identifies variants involved in autoimmunity. Nat Genet 2007;39:1329-37.
32. Thomas DC, Clayton DG. Betting odds and genetic associations. J Natl Cancer Inst 2004;96:421-3.
33. Simmonds MJ, Brand OJ, Barrett JC, et al. Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3. Clin Endocrinol 2010;73: 654-60.
34. Newby PR, Pickles OJ, Mazumdar S, et al. Follow-up of potential novel Graves' disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study. Eur J Hum Genet 2010;18:1021-6.
35. Manji N, Carr-Smith JD, Boelaert K, et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab 2006;91: 4873-80.
36. Simmonds MJ, Gough SC. Genetic insights into disease mechanisms of autoimmunity. Br Med Bull 2004;71:93-113.
37. Sirota M, Schaub MA, Batzoglou S, et al. Autoimmune disease classification by inverse association with SNP alleles. Plos Genetics 2009;5:e1000792.
38. WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
39. Hakonarson H, Grant SF, Bradfield JP, et al. A genomewide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007;448:591-4.
40. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-64.
41. Barrett JC, Clayton DG, Concannon P, etal. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-7.
42. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-53.
43. Prokopenko I, McCarthy MI, Lindgren CM. Type 2 diabetes: new genes, new understanding. Trends Genet 2008;24:613-21.
44. Conrad DF, Pinto D, Redon R, etal. Origins and functional impact of copy number variation in the human genome. Nature 2010;464:704-12.
45. Craddock N, Hurles ME, Cardin N, et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010;464:713-20.
46. Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat RevGenet 2010;11:415-25.
47. Eichler EE, Flint J, Gibson G, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat RevGenet 2010;11:446-50.
48. Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 2010;11:31-46.
49. Nejentsev S, Walker N, Riches D, et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009;324:387-9.
50. Epstein DJ. Cis-regulatory mutations in human disease. Brief Funct Genomic Proteomic 2009;8:310-6.
51. Hodge SE, Ban Y, Strug LJ, et al. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid 2006;16:351-5.
52. Nadeau JH. Transgenerational genetic effects on phenotypic variation and disease risk. Hum Mol Genet 2009;18: R202-10.
53. Kong A, Steinthorsdottir V, Masson G, et al. Parental origin of sequence variants associated with complex diseases. Nature 2009;462:868-74.
54. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-23.
55. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010;10:735-44.
56. Ban Y, Davies TF, Greenberg DA, etal. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun 2004;5:203-8.
57. Chen QY, Nadell D, Zhang XY, et al. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. JClin EndocrinolMetab 2000;85:1545-9.
58. Simmonds MJ, Howson JM, Heward JM, et al. Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 2005;76:157-63.
59. Wongsurawat T, Nakkuntod J, Charoenwongse P, et al. The association between HLA class II haplotype with Graves' disease in Thai population. Tissue Antigens 2006;67:79-83.
60. Furugaki K, Shirasawa S, Ishikawa N, et al. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet 2004;49:166-8.
61. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-11.
62. Vaidya B, Imrie H, Perros P, etal. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 1999;8:1195-9.
63. Yanagawa T, Hidaka Y, Guimaraes V, et al. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. JClin EndocrinolMetab 1995;80:41-5.
64. Heward JM, Brand OJ, Barrett JC, et al. Association of PTPN22 haplotypes with Graves' disease. J Clin Endocrinol Metab 2007;92:685-90.
65. Smyth D, Cooper JD, Collins JE, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004;53:3020-3.
66. Velaga MR, Wilson V, Jennings CE, et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004;89:5862-5.
67. Dechairo BM, Zabaneh D, Collins J, etal. Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 2005;13:1223-30.
68. Hiratani H, Bowden DW, Ikegami S, et al. Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 2005;90:2898-903.
69. Houston FA, Wilson V, Jennings CE, et al. Role of the CD40 locus in Graves' disease. Thyroid 2004;14:506-9.
70. Jacobson EM, Concepcion E, Oashi T, et al. A Graves' Disease Associated Kozak Sequence Single Nucleotide Polymorphism Enhances the Efficiency of CD40 Gene Translation: A Case for Translational Pathophysiology. Endocrinology 2005;146:2684-91.
71. Jacobson EM, Huber AK, Akeno N, et al. A CD40 Kozak sequence polymorphism and susceptibility to antibodymediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun 2007;8:205-14.
72. Tomer Y, Concepcion E, Greenberg DA. A C/T singlenucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002;12:1129-35.
73. Owen CJ, Kelly H, Eden JA, et al. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007;92:1106-11.
74. Farid NR, Barnard JM, Marshall WH. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease. Tissue Antigens 1976;8:181-9.
75. Grumet FC, Payne RO, Konishi J, et al. HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab 1974;39:1115-9.
76. Huang SM, Wu TJ, Lee TD, etal. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people. Tissue Antigens 2003;61:154-8.
77. Mather BA, Roberts DF, Scanlon MF, et al. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives. Clin Endocrinol 1980;12:155-63.
78. Simmonds MJ, Howson JM, Heward JM, et al. A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum Mol Genet 2007;16: 2149-53.
79. Sutherland A, Davies J, Owen CJ, et al. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J Clin Endocrinol Metab 2007;92:3338-41.
80. Chu X, Dong Y, Shen M, et al. Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence. BMC Med Genet 2009; 10:26.
81. Chistiakov DA, Savost'anov KV, Turakulov RI. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study. Mol Genet Metab 2004;83:264-70.
82. Yesmin K, Hargreaves C, Newby PR, et al. Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression. Clin Endocrinol 2010;73:119-25.
83. Huber AK, Jacobson EM, Jazdzewski K, et al. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 2008;93:1077-81.
84. Chu X, Dong C, Lei R, et al. Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population. Genes Immun 2009;10:260-6.
85. Yang Y, Lingling S, Ying J, et al. Association study between the IL4, IL13, IRF1 and UGRP1 genes in chromosomal 5q31 region and Chinese Graves' disease. J Hum Genet 2005;50:574-82.
86. Heward JM, Allahabadia A, Sheppard MC, et al. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501. Clin Endocrinol 1999;51:115-8.
87. Vives-Pi M, Vargas F, James RF, et al. Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity. Tissue Antigens 1997;50:153-63.
88. Newby PR, Roberts-Davies EL, Brand OJ, et al. Tag SNP screening of the PDCD1 gene for association with Graves' disease. Clin Endocrinol 2007;67:125-8.
89. Nakkuntod J, Wongsurawat T, Charoenwongse P, et al. Association of TNF-alpha, TNF-beta, IFN-gamma and IL-1Ra gene polymorphisms with Graves' disease in the Thai population. Asian Pac J Allergy Immunol 2006;24: 207-11.
90. Simmonds MJ, Heward JM, Howson JM, et al. A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease. Genes Immun 2004;5:267-73.
91. Demaine AG, Ratanachaiyavong S, Pope R, et al. Thyroglobulin antibodies in Graves' disease are associated with T-cell receptor beta chain and major histocompatibility complex loci. Clin Exp Immunol 1989;77:21-4.
92. Pickerill AP, Watson PF, Tandon N, et al. T cell receptor beta chain gene polymorphisms in Graves' disease. Acta Endocrinol 1993;128:499-502.
93. Zhang J, Hu S, Wang H. Expression of T cell receptor V(alpha) gene families in intrathyroidal T cells of Chinese patients with Graves' disease. Chin Med Sci J 2000;15:175-8.
94. Kotani T, Kato E, Hirai K, et al. Immunoglobulin G subclasses of anti-thyroid peroxidase autoantibodies in human autoimmune thyroid diseases. Endocrinol Jpn 1986; 33:505-10.
95. Kotani T, Umeki K, Matsunaga S, et al. Detection of autoantibodies to thyroid peroxidase in autoimmune thyroid diseases by micro-ELISA and immunoblotting. J Clin Endocrinol Metab 1986;62:928-33.
96. Ludgate M, Vassart G. The molecular genetics of three thyroid autoantigens: thyroglobulin, thyroid peroxidase and the thyrotropin receptor. Autoimmunity 1990;7:201-11.
97. Pirro MT, De Filippis V, Di Cerbo A, et al. Thyroperoxidase microsatellite polymorphism in thyroid diseases. Thyroid 1995;5:461-4.
98. Ban Y, Tozaki T, Tobe T, et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun 2007;28:201-7.
99. Owen CJ, Eden JA, Jennings CE, et al. Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol 2006;37:97-104.
100. Bednarczuk T, Placha G, Jazdzewski K, et al. Interleukin-13 gene polymorphisms in patients with Graves' disease. Clin Endocrinol 2003;59:519-25.
101. Hiromatsu Y, Fukutani T, Ichimura M, et al. Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease. J Clin Endocrinol Metab 2005;90:296-301.
102. Simmonds MJ, Heward JM, Franklyn JA, et al. IL-13 and chromosome 5q31-q33: problems of identifying association within regions of linkage to Graves' disease. Clin Endocrinol 2005;63:695-7.
103. Heward JM, Nithiyananthan R, Allahabadia A, et al. No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J Clin Endocrinol Metab 2001;86:3861-3.
104. Blakemore AI, Watson PF, Weetman AP, et al. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995;80: 111-5.
105. Muhlberg T, Kirchberger M, Spitzweg C, et al. Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population. Eur J Endocrinol 1998;138:686-90.
106. Collins JE, Heward JM, Howson JM, et al. Common allelic variants of exons 10,12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. J Clin Endocrinol Metab 2004;89: 6336-9.
107. Collins JE, Heward JM, Carr-Smith J, et al. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J Clin Endocrinol Metab 2003; 88:5039-42.
108. Tomer Y, Greenberg D. The thyroglobulin gene as the first thyroid-specific susceptibility gene for autoimmune thyroid disease. Trends Mol Med 2004;10:306-8.
109. Tomer Y, Greenberg DA, Concepcion E, et al. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab 2002;87:404-7.
110. Ban Y, Ban Y, Taniyama M, et al. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 2000;10:475-80.
111. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 2000;85:4639-43.
112. Collins JE, Heward JM, Nithiyananthan R, et al. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin Endocrinol 2004;60:618-24.
113. Ramos-Lopez E, Kurylowicz A, Bednarczuk T, et al. Vitamin D receptor polymorphisms are associated with Graves' disease in German and Polish but not in Serbian patients. Thyroid 2005;15:1125-30.
114. Stefanic M, Karner I, Glavas-Obrovac L, etal. Association of vitamin D receptor gene polymorphism with susceptibility to Graves' disease in Eastern Croatian population: case-control study. Croat Med J 2005;46:639-46.